Bro, my big pitch to you was what was gonna happen after hours and before the bell in the morning. I’m holding overnight. Let’s see how your one dollar does then. How the hell did you buy a 540 was there for like one second to 550 and then back down
Mark Me for The Push to 500 Member Marks-thanks-ALL POSTS and or ADVICE ARE IN MY OPINION ONLY !!
Recent PCSA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:54:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:52:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:51:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:50:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:12:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:17:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:08:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:06:41 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/23/2026 04:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:07:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:05:30 PM
- Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/12/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 01:30:50 PM
- Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study • GlobeNewswire Inc. • 01/05/2026 02:15:00 PM
- Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update • IH Market News • 12/17/2025 03:10:16 PM
- Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer • GlobeNewswire Inc. • 12/17/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 04:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:07:39 PM
- Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 • GlobeNewswire Inc. • 11/05/2025 02:15:00 PM
